rhabdomyolysis
14 interactions related to rhabdomyolysis
clarithromycin + red yeast rice
Clarithromycin is a strong CYP3A4 inhibitor. Red yeast rice's active compound, monacolin K, is chemically identical to the statin lovastatin and is cleared mainly by CYP3A4. Combining them slows clearance of the statin-like compound and raises its blood levels, increasing the risk of muscle injury and, rarely, rhabdomyolysis.
lovastatin + red yeast rice
Red yeast rice contains monacolin K, which is chemically identical to the statin lovastatin. Taking red yeast rice together with prescription lovastatin means taking the same statin twice, adding to HMG-CoA reductase inhibition and raising the risk of muscle injury (including rhabdomyolysis) and liver harm. Because the amount of monacolin K in red yeast rice is variable and usually not stated on the label, the added statin exposure is unpredictable and stacks on top of an already-active prescription dose.
gemfibrozil + red yeast rice
Red yeast rice supplies monacolin K, a compound chemically identical to the statin lovastatin. Combining it with gemfibrozil, a fibrate, can add up to serious muscle injury. The fibrate is itself toxic to muscle and also raises circulating statin levels by interfering with how the statin is cleared, so the two effects stack toward myopathy and, in the worst case, rhabdomyolysis with kidney injury.
simvastatin + red yeast rice
Red yeast rice contains monacolin K, which is chemically identical to the prescription statin lovastatin. Adding it to simvastatin stacks two statins with the same mechanism and metabolism, adding to the risk of muscle injury, rhabdomyolysis, and liver problems.
atorvastatin + niacin
Adding cholesterol-dose niacin to atorvastatin raises the risk of muscle injury (myopathy, rarely rhabdomyolysis) without improving cardiovascular outcomes in patients already well treated with a statin.
lovastatin + grapefruit
Grapefruit blocks the intestinal enzyme CYP3A4 that normally limits how much lovastatin reaches your bloodstream. With that enzyme suppressed, lovastatin levels can rise sharply, raising the risk of muscle injury and, rarely, rhabdomyolysis. Spacing the timing does not help because the effect lasts for days.
simvastatin + berberine
Simvastatin is activated and cleared by the CYP3A4 enzyme. A human study found that repeated berberine inhibits CYP3A4, which could raise simvastatin levels and increase the risk of muscle-related side effects. Some animal data suggest berberine can also induce CYP3A4 over time, so the net effect on statin exposure is hard to predict. There are no published human case reports of myopathy from this specific combination, so the concern is mechanistic and moderate.
atorvastatin + red yeast rice
Red yeast rice naturally contains monacolin K, the same compound as the prescription statin lovastatin. Taking it alongside atorvastatin effectively stacks two statins working through the same liver pathway, raising the risk of statin-associated muscle symptoms, rhabdomyolysis, and liver injury.
seville orange + atorvastatin
Seville (bitter) orange contains the same furanocoumarins as grapefruit, including bergamottin and 6',7'-dihydroxybergamottin, which inactivate intestinal CYP3A4. A randomized crossover study showed Seville orange juice raised levels of the CYP3A4 drug felodipine to a degree comparable with grapefruit juice, while ordinary sweet orange juice had no effect. Because atorvastatin is metabolised by the same CYP3A4 pathway, Seville orange can raise atorvastatin levels and increase the risk of statin-related muscle injury.
pomegranate + statins
Pomegranate inhibits the drug-metabolizing enzyme CYP3A4 in laboratory and animal studies, raising a theoretical concern that it could increase blood levels of CYP3A4-dependent statins such as simvastatin, atorvastatin, and lovastatin. However, controlled human studies - including ones using simvastatin and a sensitive CYP3A4 probe drug - did not find a meaningful effect, so pomegranate should not be treated like grapefruit. Concentrated pomegranate extract supplements warrant more caution than the whole fruit.
alcohol + statins
Statins and alcohol are both processed by the liver, and heavy or chronic combined use can add to the strain on liver cells, modestly raising the risk of liver enzyme elevation and, less commonly, muscle problems. In people with established alcohol-related liver disease, statin levels in the blood can run higher than normal. For most people who drink lightly to moderately, a statin is still safe with routine monitoring.
cbd + simvastatin
Simvastatin is cleared mainly by the liver enzyme CYP3A4, and CBD inhibits that same enzyme. Combining them is expected to raise simvastatin exposure, which could increase the risk of muscle pain and, rarely, more serious muscle injury. This is a predicted, mechanism-based interaction rather than one confirmed by a direct human study.
pomelo + simvastatin
Pomelo (Citrus maxima) contains furanocoumarins that inhibit intestinal CYP3A4, the enzyme that breaks down simvastatin during first-pass absorption. With that enzyme suppressed, more simvastatin reaches the bloodstream, raising the risk of muscle-related side effects. This is the same mechanism behind the well-established grapefruit-simvastatin interaction, since pomelo is the parent species of grapefruit and shares its furanocoumarins.
atorvastatin + berberine
In human trials, adding berberine to a statin did not raise muscle or liver side effects, and the two are sometimes studied together for cholesterol. The earlier claim that berberine meaningfully raises atorvastatin levels and risk is not supported by human evidence.